Cyclophilins: Potential Drug Targets for Various Diseases (P45120)

Target Name: Cyclophilins

NCBI ID: P45120

Cyclophilins

Other Name(s): None

Cyclophilins: Potential Drug Targets for Various Diseases

Cyclophilins are a family of proteins that play a critical role in various physiological processes in the body. They are involved in the regulation of cell signaling, DNA replication, and metabolism. Cyclophilins have been identified as potential drug targets and biomarkers for various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases.

The discovery of cyclophilins as potential drug targets stems from their ability to modulate gene expression and control cellular processes that are associated with the development and progression of many diseases. Cyclophilins have been shown to play a role in the regulation of cell proliferation, apoptosis, angiogenesis, and inflammation. They have also been implicated in the development and progression of various cancers, including breast, ovarian, and prostate cancers.

One of the key features of cyclophilins is their ability to interact with various signaling pathways. Cyclophilins have been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell proliferation, survival, and angiogenesis. Cyclophilins have also been shown to interact with the TGF-β signaling pathway, which is involved in the regulation of cell growth, differentiation, and inflammation.

In addition to their involvement in cellular signaling pathways, cyclophilins have also been shown to play a role in the regulation of DNA replication and metabolism. Cyclophilins have been shown to interact with the DNA replication complex, which is involved in the regulation of DNA replication in cells. They have also been shown to play a role in the regulation of metabolism, including the regulation of glucose metabolism and the metabolism of fatty acids.

The identification of cyclophilins as potential drug targets has led to a significant increase in research on their biology and the development of new treatments for various diseases. Cyclophilins have also been shown to be potential biomarkers for a variety of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases.

In conclusion, cyclophilins are a family of proteins that play a critical role in various physiological processes in the body. They have been shown to be involved in the regulation of cell signaling, DNA replication, and metabolism, and have been implicated in the development and progression of various diseases. As a result, cyclophilins have emerged as a promising area of research and a potential drug target for the treatment of a variety of diseases. Further research is needed to fully understand the biology of cyclophilins and their potential as drug targets.

Protein Name: Cyclophilins (nonspecified Subtype)

The "Cyclophilins Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Cyclophilins comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets